The global Cytomegalovirus Market research report 2029, as published by Data bridge Market Research, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters.

This Cytomegalovirus market research report identifies the competitive landscape of industries, offering a comprehensive understanding of international competition. The study outlines the anticipated growth of the global market during forecast period. Compiled with a blend of static and dynamic perspectives, this research report captures the essence of the businesses views.

Data Bridge Market Research analyses that the cytomegalovirus market was valued at USD 535.70 million in 2021 and is expected to reach USD 886.57 million by 2029, registering a CAGR of 6.50% during the forecast period of 2022 to 2029.

Top Companies in the Global Cytomegalovirus Market:
Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Zydus Cadila (India), Lupin (India), Cipla Inc. (U.S.), Aurobindo Pharma (India), Glenmark Pharmaceuticals Limited (India), Endo International plc (Ireland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), Abbott (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (U.S.), among others.

Grab Sample PDF Copy of Report:

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cytomegalovirus-market

Market Segmentation:

The cytomegalovirus market is segmented on the basis of diagnosis, diseases, drugs, application, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

  • Serologic Test
  • Polymerase Chain Reaction (PCR) Test
  • Others

Diseases

  • Retinitis
  • Pneumonia
  • Gastrointestinal Ulcers
  • Encephalitis
  • Others

Drug

  • Cidofovir
  • Foscarnet
  • Valganciclovir
  • Ganciclovir
  • Others

Application

  • Stem Cell Transplantation
  • Organ Transplantation
  • Congenital CMV Infection
  • Other

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Geographically, the detailed analysis of consumption, revenue, market share, and growth rate of the following regions:

– Middle East and Africa (South Africa, Saudi Arabia, UAE, Israel, Egypt, etc.)

– North America (United States, Mexico & Canada)

– South America (Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, etc.)

– Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)

– Asia-Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).

North America dominates the cytomegalovirus market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, introduction of newer drugs will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to large number of generic manufacturer in this region. Also, development of healthcare infrastructure and rising number of population will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Browse The Report Description:

https://www.databridgemarketresearch.com/reports/global-cytomegalovirus-market

Market Dynamics

Drivers

  • Rise in the prevalence of cytomegalovirus infection

The surging prevalence of cytomegalovirus infection is a major factor driving the market's growth rate during the forecast period of 2022-2029. In the United States, one in every 150 infants is born with congenital cytomegalovirus (CMV) infection, according to the Centers for Disease Control and Prevention (CDC). Only one out of every five infants infected with CMV develops long-term health issues. The CMV infection treatment and diagnosis market will rise due to rising infection rates and desire for improved treatment options.

  • Growing prevalence of viral infections

The need for cytomegalovirus medicines is expected to rise as the prevalence of viral infections among AIDS patient’s increases due to weakening immune systems. According to the CDC, around 36.7 million people were living with human immunodeficiency virus (HIV) infection in 2017. The widespread availability of antiviral medications to treat this condition is anticipated to stimulate the demand for effective treatment options. This will influence the market’s growth rate.

Furthermore, sedentary lifestyle of people and rising number of initiatives by government to spread awareness will result in the expansion of cytomegalovirus market. Along with this, rising healthcare expenditure and expiry of patents which leads to the availability of generic drugs will enhance the growth rate of the market. Also, increasing number of organ transplantation globally is estimated to enhance the market’s growth rate.

Opportunities

  • Increase in the number of research and development activities

The rising number of research and development activities for new indications and patent expiry of biologics is estimated to create new opportunities for the cytomegalovirus market growth in coming years. Various projects focused on R&D efforts linked to cytomegalovirus (CMV) infection are being launched by major institutes. For instance, the University of Washington's Program for Advanced Cell Therapy (PACT) launched a first-in-the-US cell-therapy trial for kidney transplant patients in August 2019 that will use virus-specific white blood cells in the treatment of patients with severe cytomegalovirus (CMV) infection after kidney transplantation.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the cytomegalovirus market growth during the forecast period.

Browse Other Trending Reports:

Global Alloy Safety Valve Market – Industry Trends and Forecast to 2029
https://www.databridgemarketresearch.com/reports/global-alloy-safety-valve-market

Global Aquafeed Acidifiers Market – Industry Trends and Forecast to 2028
https://www.databridgemarketresearch.com/reports/global-aquafeed-acidifiers-market

Global Automotive Gudgeon Pin Market – Industry Trends and Forecast to 2028
https://www.databridgemarketresearch.com/reports/global-automotive-gudgeon-pin-market

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com